160405- Emotra- PM- Documents for AGM Årsredovisning 2015
Documents prepared for the Annual General Meeting
read more
INVESTORS
Article in Laika
160404- Emotra - Newsletter - Commissioned article in Laika
Notice of Emotra’s Annual General Meeting
160323- Emotra- PM- Notice of AGM
A quick update – EDOR™ in the spotlight in Madrid
160316- Emotra - Newsletter - Successful meeting in Madrid
The first stage of our clinical study has now been completed
160311 - Emotra - PM - First stage of study completed
Short update – Grant Agreement signed with the European Commission
160303- Emotra - Newsletter- Grant Agreement signed
A short update from Emotra – Kickoff for Horizon 2020 and a conference in Madrid
160218- Emotra - Newsletter - Kickoff H2020
Emotra AB (publ) Full year report 2015
160211- Full-year report 2015
Emotra granted financial support from the EU Horizon 2020
Emotra AB announces that the Company has been granted financial support from the EU Horizon 2020 programme. The application, submitted in December 2015, is for a €50K grant to finance a phase 1 feasibility study to demonstrate the potential to broaden the EDOR...
A short update from Emotra – Presentation in Sao Paolo
Lars-Håkan Thorell, the inventor of EDOR, has been invited to be one of the keynote speakers at a large conference on bipolar disorders being held in Sao Paulo, Brazil, on August 22–23, 2016. At this conference he will present EDOR and the research behind the method,...